Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
about
Fungal colonization of the respiratory tract in allogeneic and autologous hematopoietic stem cell transplant recipients: a study of 573 transplanted patients.Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropeniaThe importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update.Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology.Epidemiology of invasive fungal diseases in children with solid tumours undergoing autologous haematopoietic stem cell transplantation: a 10-year experience in a tertiary Italian centre.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid TumorsCytomegalovirus disease in children with acute lymphoblastic leukemia.Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.Treatment-related mortality in relapsed childhood acute lymphoblastic leukemia.Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.
P2860
Q35579273-8E8DE65F-8C23-4F2A-862B-6DD3A49A0313Q35589175-E8DF7DB1-D439-4065-874C-ED20670A2541Q37660511-BAF90CF9-B3C6-4948-AD47-701100DB57AFQ38264086-16A66389-3CF8-4255-94D7-D7625EBA0D5EQ38284455-4B84A102-964D-439A-9620-6BCE422458C0Q38353420-A1312CB0-24B9-4AA4-BB34-768A54B33561Q38388198-0F915799-2420-4156-AFC0-1EB2016CAA0AQ38822532-FFCEC0EF-239A-4C94-9EFA-7F61C5127966Q38827118-C947EB0C-E2B8-49B9-9E57-5157B807B901Q38965488-D6798BD6-3B15-414B-B2CB-420C2DECCD0EQ39391307-39E23AC1-FD5D-4547-AC6C-3F6CA4FDDF32Q39693447-185FD4AB-A105-40B9-BDA8-008F15084E80Q39704919-E277492E-FC68-473A-8B90-32A3C7EF6722Q41996456-106F53A7-7415-49CC-B409-BCA1D2CE48A5Q47566809-C033DB06-C312-4044-9B74-5AD704B19398Q52720488-21B9D3BB-1A74-49F2-A9AC-4F9FD0785856Q54973296-DC37CFCA-A81C-4B2E-9BF6-04C5E9F6EBBB
P2860
Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Guideline for primary antifung ...... em cell transplant recipients.
@en
type
label
Guideline for primary antifung ...... em cell transplant recipients.
@en
prefLabel
Guideline for primary antifung ...... em cell transplant recipients.
@en
P2093
P2860
P356
P1476
Guideline for primary antifung ...... tem cell transplant recipients
@en
P2093
Lillian Sung
Michelle Science
Paula D Robinson
Tamara MacDonald
P2860
P304
P356
10.1002/PBC.24847
P577
2013-11-26T00:00:00Z